These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27727515)
1. Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes. Mori H; Kuroda A; Araki M; Suzuki R; Taniguchi S; Tamaki M; Akehi Y; Matsuhisa M J Diabetes Investig; 2017 May; 8(3):377-382. PubMed ID: 27727515 [TBL] [Abstract][Full Text] [Related]
2. Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes. Mori H; Kuroda A; Ishizu M; Ohishi M; Takashi Y; Otsuka Y; Taniguchi S; Tamaki M; Kurahashi K; Yoshida S; Endo I; Aihara KI; Funaki M; Akehi Y; Matsuhisa M J Diabetes Investig; 2019 Sep; 10(5):1332-1340. PubMed ID: 30677242 [TBL] [Abstract][Full Text] [Related]
3. Relationship between advanced glycation end-product accumulation and low skeletal muscle mass in Japanese men and women. Kato M; Kubo A; Sugioka Y; Mitsui R; Fukuhara N; Nihei F; Takeda Y Geriatr Gerontol Int; 2017 May; 17(5):785-790. PubMed ID: 27119258 [TBL] [Abstract][Full Text] [Related]
4. Dermal advanced glycation end-product accumulation is associated with sarcopenia-related measures in middle-aged and older men. Matsumoto S; Ochi M; Akechi Y; Takei S; Senzaki K; Okada Y; Miura S; Ochi H; Igase M; Ohyagi Y Arch Gerontol Geriatr; 2022; 101():104704. PubMed ID: 35461167 [TBL] [Abstract][Full Text] [Related]
5. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia. Waqas K; Chen J; Trajanoska K; Ikram MA; Uitterlinden AG; Rivadeneira F; Zillikens MC J Clin Endocrinol Metab; 2022 Jan; 107(2):e793-e803. PubMed ID: 34453164 [TBL] [Abstract][Full Text] [Related]
6. High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study. Mori H; Kuroda A; Yoshida S; Yasuda T; Umayahara Y; Shimizu S; Ryomoto K; Yoshiuchi K; Yamamoto T; Matsuoka TA; Shimomura I; Matsuhisa M J Diabetes Investig; 2021 Jun; 12(6):1050-1059. PubMed ID: 33063949 [TBL] [Abstract][Full Text] [Related]
7. A Cross-Sectional Analysis of Receptor for Advanced Glycation End Products in Human Skeletal Muscle: A Comparative Analysis between Patients with and without Sarcopenia. Hwang JS; Kwon HJ; Gong HS Gerontology; 2023; 69(5):526-532. PubMed ID: 36587609 [TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes. Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146 [TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products are associated with sarcopenia in older women: aging marker dynamics. Eguchi Y; Toyoguchi T; Inage K; Fujimoto K; Orita S; Suzuki M; Kanamoto H; Abe K; Norimoto M; Umimura T; Koda M; Furuya T; Aoki Y; Nakamura J; Akazawa T; Takahashi K; Ohtori S J Women Aging; 2021; 33(3):328-340. PubMed ID: 31770087 [TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes. Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970 [TBL] [Abstract][Full Text] [Related]
11. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study. Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products in skeletal muscle health and sarcopenia: A systematic review of observational studies. Granic A; Hurst C; Dismore L; Dodds RM; Witham MD; Robinson SM; Sayer AA Mech Ageing Dev; 2023 Jan; 209():111744. PubMed ID: 36368549 [TBL] [Abstract][Full Text] [Related]
13. Reduced leg muscle mass and lower grip strength in women are associated with osteoporotic vertebral compression fractures. Eguchi Y; Toyoguchi T; Orita S; Shimazu K; Inage K; Fujimoto K; Suzuki M; Norimoto M; Umimura T; Shiga Y; Inoue M; Koda M; Furuya T; Maki S; Hirosawa N; Aoki Y; Nakamura J; Hagiwara S; Akazawa T; Takahashi H; Takahashi K; Shiko Y; Kawasaki Y; Ohtori S Arch Osteoporos; 2019 Nov; 14(1):112. PubMed ID: 31760559 [TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study. Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469 [TBL] [Abstract][Full Text] [Related]
15. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881 [TBL] [Abstract][Full Text] [Related]
16. Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men. Momma H; Niu K; Kobayashi Y; Guan L; Sato M; Guo H; Chujo M; Otomo A; Yufei C; Tadaura H; Saito T; Mori T; Miyata T; Nagatomi R Osteoporos Int; 2012 Jun; 23(6):1673-81. PubMed ID: 21901479 [TBL] [Abstract][Full Text] [Related]
17. Skin advanced glycation end product accumulation and muscle strength among adult men. Momma H; Niu K; Kobayashi Y; Guan L; Sato M; Guo H; Chujo M; Otomo A; Yufei C; Tadaura H; Saito T; Mori T; Miyata T; Nagatomi R Eur J Appl Physiol; 2011 Jul; 111(7):1545-52. PubMed ID: 21188413 [TBL] [Abstract][Full Text] [Related]
18. Clinical impact of sarcopenia and dynapenia on diabetes. Mori H; Kuroda A; Matsuhisa M Diabetol Int; 2019 Jul; 10(3):183-187. PubMed ID: 31275784 [TBL] [Abstract][Full Text] [Related]
19. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes. Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334 [TBL] [Abstract][Full Text] [Related]
20. [Research Progress in the Role of Advanced Glycation End Products in the Pathogenesis of Sarcopenia]. Zhang XY; Guo Q; Chen XY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):111-118. PubMed ID: 38433640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]